A numerical model for transdermal drug delivery (TDD) has been developed by treating skin as a composite, dynamic, porous medium. Governing unsteady mass transport equations in porous medium was solved for different cases for up to a period of drug-patch application of 10 hrs. The effects of cell migration and anisotropic diffusive properties of stratum corneum (SC) on TDD are analyzed. Each of the above factors and their combination are found to significantly affect TDD. The cell migration in SC decreases the predicted amount of drug considerably. Their combined effect in TDD helped in identifying four distinct regimes of pharmacological as well as engineering importance within the domain.
Issue Section:
Research Papers
Keywords:
Bio-Heat and mass transfer
References
References
1.
Scheuplein
, R. J.
1967
, “Mechanism of Percutaneous Absorption
,” J. Invest. Dermatol.
, 48
(1
), pp. 79
–88
.2.
Hadgraft
, J.
Guy
, R. H.
1989
, Transdermal Drug Delivery: Developmental Issues and Research Initiatives
, Vol. 35
, Marcel Dekker
, New York
.3.
Waters
, C.
2013
, “The Development of the Rotigotine Transdermal Patch: A Historical Perspective
,” Neurol. Clin.
, 31
(Suppl. 3
), pp. S37
–S50
.4.
Wohlrab
, J.
Kreft
, B.
Tamke
, B.
2011
, “Skin Tolerability of Transdermal Patches
,” Expert Opin. Drug Delivery
, 8
(7
), pp. 939
–948
.5.
Barry
, B.
2001
, “Novel Mechanisms and Devices to Enable Successful Transdermal Drug Delivery
,” Eur. J. Pharm. Sci.
, 14
(2
), pp. 101
–114
.6.
Kretsos
, K.
Miller
, M. A.
Zamora-Estrada
, G.
Kasting
, G. B.
2008
, “Partitioning, Diffusivity and Clearance of Skin Permeants in Mammalian Dermis
,” Int. J. Pharm.
, 346
(1–2
), pp. 64
–79
.7.
Khalil
, E.
Kretsos
, K.
Kasting
, G.
2006
, “Glucose Partition Coefficient and Diffusivity in the Lower Skin Layers
,” Pharm. Res.
, 23
(6
), pp. 1227
–1234
.8.
Frederick Frasch
, H.
2002
, “A Random Walk Model of Skin Permeation
,” Risk Anal.
, 22
(2
), pp. 265
–276
.9.
Montagna
, W.
1974
, The Structure and Function of Skin 3E
, Academic Press
, New York
.10.
Heisig
, M.
Lieckfeldt
, R.
Wittum
, G.
Mazurkevich
, G.
Lee
, G.
1996
, “Non Steady-State Descriptions of Drug Permeation Through Stratum Corneum. I. The Biphasic Brick-and-Mortar Model
,” Pharm. Res.
, 13
(3
), pp. 421
–426
.11.
Park
, J.-H.
Choi
, S.-O.
Seo
, S.
Choy
, Y. B.
Prausnitz
, M. R.
2010
, “A Microneedle Roller for Transdermal Drug Delivery
,” Eur. J. Pharm. Biopharm.
, 76
(2
), pp. 282
–289
.12.
Petersen
, K. K.
Rousing
, M. L.
Jensen
, C.
Arendt-Nielsen
, L.
Gazerani
, P.
2011
, “Effect of Local Controlled Heat on Transdermal Delivery of Nicotine
,” Int. J. Physiol., Pathophysiol. Pharmacol.
, 3
(3
), pp. 236
–242
.13.
Cross
, S. E.
Roberts
, M. S.
1995
, “Importance of Dermal Blood Supply and Epidermis on the Transdermal Iontophoretic Delivery of Monovalent Cations
,” J. Pharm. Sci.
, 84
(5
), pp. 584
–592
.14.
Hadgraft
, J.
1999
, “Passive Enhancement Strategies in Topical and Transdermal Drug Delivery
,” Int. J. Pharm.
, 184
(1
), pp. 1
–6
.15.
Kalia
, Y. N.
Guy
, R. H.
2001
, “Modeling Transdermal Drug Release
,” Adv. Drug Delivery Rev.
, 48
(2
), pp. 159
–172
.16.
Iordanskii
, A. L.
Feldstein
, M. M.
Markin
, V. S.
Hadgraft
, J.
Plate
, N. A.
2000
, “Modeling of the Drug Delivery From a Hydrophilic Transdermal Therapeutic System Across Polymer Membrane
,” Eur. J. Pharm. Biopharm.
, 49
(3
), pp. 287
–293
.17.
Manitz
, R.
Lucht
, W.
Strehmel
, K.
Weiner
, R.
Neubert
, R.
1998
, “On Mathematical Modeling of Dermal and Transdermal Drug Delivery
,” J. Pharm. Sci.
, 87
(7
), pp. 873
–879
.18.
Rim
, J. E.
Pinsky
, P. M.
van Osdol
, W. W.
2009
, “Multiscale Modeling Framework of Transdermal Drug Delivery
,” Ann. Biomed. Eng.
, 37
(6
), pp. 1217
–1229
.19.
Lv
, Y.
Liu
, J.
Gao
, Y.
Xu
, B.
2006
, “Modeling of Transdermal Drug Delivery With a Microneedle Array
,” J. Micromech. Microeng.
, 16
(11
), pp. 2492
–2501
.20.
Mehdizadeh
, A.
Toliate
, T.
Rouini
, M. R.
Abashzadeh
, S.
Dorkoosh
, F.
2004
, “Design and In Vitro Evaluation of New Drug-in-Adhesive Formulations of Fentanyl Transdermal Patches
,” Acta Pharm.
, 54
(4
), pp. 301
–317
.21.
Hadgraft
, J.
Guy
, R. H.
2010
, Transdermal Drug Delivery
, 2nd ed.
, Vol. 123
, Informa Healthcare
, London
.22.
Filer
, C.
Allen
, G.
Brown
, T.
Fowles
, S.
Hollis
, F.
Mort
, E.
Prince
, W.
Ramji
, J.
1994
, “Metabolic and Pharmacokinetic Studies Following Oral Administration of 14C-Famciclovir to Healthy Subjects
,” Xenobiotica
, 24
(4
), pp. 357
–368
.23.
Narasimhan
, A.
2013
, Essentials of Heat and Fluid Flow in Porous Media
, ANE Books
, New Delhi, India
.24.
Alberti
, I.
Kalia
, Y. N.
Naik
, A.
Bonny
, J.-D.
Guy
, R. H.
2001
, “In Vivo Assessment of Enhanced Topical Delivery of Terbinafine to Human Stratum Corneum
,” J. Controlled Release
, 71
(3
), pp. 319
–327
.25.
Lowes
, M. A.
Bowcock
, A. M.
Krueger
, J. G.
2007
, “Pathogenesis and Therapy of Psoriasis
,” Nature
, 445
(7130
), pp. 866
–873
.26.
Benson
, H. A.
2005
, “Transdermal Drug Delivery: Penetration Enhancement Techniques
,” Curr. Drug Delivery
, 2
(1
), pp. 23
–33
.27.
Kramer
, C.
Tawney
, M.
1998
, “A Fatal Overdose of Transdermally Administered Fentanyl
,” J. Am. Osteopath. Assoc.
, 98
(7
), pp. 385
–386
.28.
Tanner
, T.
Marks
, R.
2008
, “Delivering Drugs by the Transdermal Route: Review and Comment
,” Skin Res. Technol.
, 14
(3
), pp. 249
–260
.29.
Ale
, I.
Lachapelle
, J.-M.
Maibach
, H.
2009
, “Skin Tolerability Associated With Transdermal Drug Delivery Systems: An Overview
,” Adv. Ther.
, 26
(10
), pp. 920
–935
.30.
Zhai
, H.
Maibach
, H. I.
2001
, “Skin Occlusion and Irritant and Allergic Contact Dermatitis: An Overview
,” Contact Dermatitis
, 44
(4
), pp. 201
–206
.Copyright © 2015 by ASME
You do not currently have access to this content.
